In patients with HCC secondary to MASLD and ALD, low serum albumin levels and an elevated CRP/albumin ratio are strong predictors of early mortality at diagnosis, reflecting the central prognostic role of hepatic functional reserve and systemic inflammation in this population, highlighting the predominant contribution of hepatic functional reserve and systemic inflammation in this setting. The gene discussed is ALB; the disease is hepatocellular carcinoma.